Entasis Therapeutics - ETTX

[investar]

Low float

Spinout of AstraZeneca

presentation https://investors.entasistx.com/static- ... 3d5ed53472

2 Phase 3 stories... Precision Antibiotics. MDR Strains and ghonorrea

Sul/Dur, partnered ZLAB

news expected April, maybe May

Good idea to load up here, while no one has noticed it yet

https://www.entasistx.com/

[investar]

Innoviva took another position at 2$

Good, excellent entry point here and now.
The float is very thin!!!

https://finance.yahoo.com/news/entasis- ... 00603.html

[investar]

Good news (pre-clinical data) for ETX0462, a novel, first-in-class, diazabicyclooctane with antimicrobial activity against multidrug-resistant (MDR) Gram-negative and biothreat pathogens, at the 2021 World Microbe Forum


ETX0462 potentially represents the first new antibiotic class in 35 years to treat MDR Gram-negative and biothreat infections.

One of the best smallcap biotechs at this moment and price imo... The 2.6 level of today might become 12,6 next year!

[investar]

Great Phase III results, very disappointing market reaction.
One would rather think a double is in place after such remarkable de-risking event...
no, the shares are actually much cheaper than last week.
Maybe because the market expected INVA to buy up all the remaining shares immediately?

I have time with this one, especially now.

https://investors.entasistx.com/news-re ... ne-results